share_log

COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch

COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch

夏季激增期間,26個州的COVID活動處於高水平,拜登仍處於隔離狀態:3只生物-疫苗股票值得關注
Benzinga ·  15:59

More than half of the states in the U.S. are experiencing significant Covid-19 activity in wastewater, and President Joe Biden remains in isolation after announcing Wednesday he caught the virus for the third time.

美國超過一半的州的廢水中都存在顯著的 Covid-19 活動,喬·拜登總統週三宣佈他第三次感染該病毒而仍處於隔離狀態。

Twenty-six states are reporting either "high" or "very high" levels of the virus at various sites, according to the latest data from the Centers for Disease Control and Prevention.

根據美國疾病控制和預防中心的最新數據,有26個州的各個地點報告了"高"或"非常高"的病毒水平。

States with the highest levels include Arkansas, California, Florida, Maryland, Nevada, Oregon and Texas.

病毒水平最高的州包括阿肯色州、加利福尼亞州、佛羅里達州、馬里蘭州、內華達州、俄勒岡州和德克薩斯州。

The Biden administration no longer considers Covid-19 a public health emergency and instead treats it as a routine respiratory virus to be prevented through an annual vaccination campaign, the Washington Post reported.

《華盛頓郵報》報道,拜登政府不再將 Covid-19 視爲公共衛生緊急情況,而是將其作爲一種常見的呼吸道病毒進行預防,可通過年度疫苗接種來預防。

Also Read: European Commission Faces Court Criticism Over COVID Vaccine Contract Transparency Ahead Of Vote on Ursula Von Der Leyen's Reappointment

歐洲委員會面臨各方批評,因在烏蘇拉·馮德萊恩重獲委任前公佈 Covid 疫苗相關合同的透明度不足。

Biden is staying at his Rehoboth Beach home in Delaware while continuing to perform presidential duties.

拜登在特拉華州的他的雷霍博斯海灘住宅內繼續履行總統職務。

Vaccine Stocks To Watch: Novovax, Inc. (NASDAQ:NVAX), Moderna, Inc. (NASDAQ:MRNA) and Pfizer Inc. (NYSE:PFE) are all making new Covid vaccines that should be available before the end of September, the New York Times reported.

疫苗股票關注點:諾瓦瓦克斯醫藥(納斯達克股票代碼:NVAX)、Moderna,Inc.(納斯達克股票代碼:MRNA)和輝瑞公司(紐約證券交易所代碼:PFE)都在製造新的 Covid 疫苗,預計將在9月底前上市,據《紐約時報》報道。

The Novavax vaccine will target JN.1, the variant that was prominent in the winter and spring.

諾瓦瓦克斯醫藥將以冬季和春季突出的 JN.1 變種爲目標。

Pfizer and Moderna are developing shots aimed at KP.2, which accounts for about one in four new cases. Two related variants, KP.3 and LB.1, are the culprint behind more than half of new cases, the Times said.

輝瑞和Moderna正在開發針對佔新病例四分之一的 KP.2 變體的疫苗。KP.3 和 Lb.1 兩個相關變異體是導致過半新病例的罪魁禍首,《紐約時報》稱。

All three variants are descendants of JN.1, so each of the vaccines is expected to be effective against them.

這三個變體都是 JN.1 的後代,因此預計每種疫苗都將對其有效。

NVAX, MRNA, PFE Price Action: Novovax shares were down 5.7% to $14.94 late in Thursday's session. Moderna was down 2.16% to $121.37. Pfizer is down 1.07% at $29.70.

Novovax 的股票在週四的交易中晚些時候下跌了5.7%,至14.94美元。Moderna 股價下跌2.16%,至121.37美元。輝瑞股價下跌1.07%,至29.70美元。

Exchange-traded funds that hold shares of Pfizer, which has the largest market capitalization of the group of vaccine developers at $169 billion, declined in Thursday afternoon trading.

持有輝瑞股票的交易所交易基金(ETF)在週四下午的交易中下跌。輝瑞疫苗開發組中市值最大的公司市值達1690億美元。

  • First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTHX) fell 0.35%.
  • First Trust Morningstar Dividend Leaders Index Fund (NYSE:FDL) slipped 0.69%.
  • Invesco Pharmceuticals ETF (NYSE:PJP) slid 0.55%.
  • Harbor Health Care ETF (NYSE:MEDI) lost 0.33%.
  • Invesco S&P Ultra dividend Revenue ETF (NYSE:RDIV) declined 0.66%.
  • 景順納斯達克醫藥ETF(納斯達克股票代碼:FTHX)下跌了0.35%。
  • 第一產業晨星股息領袖指數基金(紐約證券交易所股票代碼:FDL)下跌了0.69%。
  • 英威視藥物ETF(紐約證券交易所股票代碼:PJP)下跌了0.55%。
  • Harbor 醫療保健ETF(紐約證券交易所代碼:MEDI)下跌了0.33%。
  • 英威視標普超級股息收入ETF(紐約證券交易所股票代碼:RDIV)下跌了0.66%。

Read Now:

立即閱讀:

  • Moderna, Regeneron Pharmaceuticals And 2 Other Stocks Insiders Are Selling
  • Moderna、再生元製藥公司和其他2只股票的內部人士正在拋售

Photo via Shutterstock.

圖片來自Shutterstock。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論